Mode
Text Size
Log in / Sign up
N/A N=153 Treatment

Clinical Evaluation of Ajust™ in Stress Urinary Incontinence

Female Stress Urinary Incontinence

Enrolled (actual)
153
Serious AEs
1.3%
Results posted
May 2014
Primary outcome: Primary: Percentage of Patients Free of Stress Urinary Incontinence — 92.8 percentage of participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Ajust Adjustable Single-Incision Sling (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
C. R. Bard
Primary completion
Jun 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Patients Free of Stress Urinary Incontinence
92.8
PRIMARY
Percentage of Subjects Who Showed Improvement in Self-reported SUI Symptoms at 12 Months
79.3
SECONDARY
Operative, Perioperative and Long-Term Complications During Operative Procedure
11.8
SECONDARY
Operative, Perioperative and Long-Term Complications Perioperatively
2.6
SECONDARY
Operative, Perioperative and Long-term Complications Through 36 Months
8.5
SECONDARY
Change in Post-operative Pain
-79.7
SECONDARY
Percentage of Subjects Who Showed Improvement in Self-reported SUI Symptoms at 36 Months
55.3
SECONDARY
Change in Incontinent Impact Questionnaire at 12 Months
-32.9
SECONDARY
Change in Incontinent Impact Questionnaire at 36 Months
-29.7
SECONDARY
Percentage of Patients With Impression of Improvement With Procedure at 12 Months
94.9
SECONDARY
Percentage of Patients With Impression of Improvement With Procedure at 36 Months
81.3

Summary

The purpose of this study is to assess the overall effectiveness of the Ajust Adjustable Single-Incision Sling in the surgical treatment of female stress urinary incontinence.

Eligibility Criteria

Inclusion Criteria

  • Female, age at least 18 years
  • Have signed an Informed Consent Form
  • Has been diagnosed with stress urinary incontinence as documented by: a minimum 30-degree urethral deflection, considered to be a candidate for transobturator repair by consulting surgeon (investigator), has a positive CST
  • Desires surgical correction of SUI using the Ajust™ Adjustable Single-Incision Sling

Exclusion Criteria

  • Patient is actively participating in any other genitourinary clinical trial of an experimental drug or device
  • Patient is known to be pregnant or desiring future childbearing
  • Patient has a known urinary tract infection, or known infection in the operative field at the time of device implantation
  • Patient is unable to have their anticoagulation therapy suspended for the completion of the surgical procedure
  • Patient requires concurrent correction of pelvic organ prolapse
  • Patient has a history of previous sling procedure
  • Patient has known history of detrusor overactivity demonstrated by urodynamics
  • Patient has known urinary retention
  • Patient has a current genitourinary fistula or urinary diverticulum
  • Patient has a prior history of pelvic radiation
  • Patient has a MESA urge symptom score (% of total possible urge score) that is greater than their MESA stress symptom score (% of total possible stress score)
  • Any condition in the opinion of the Investigator that would preclude the use of the Ajust™ Adjustable Single-Incision Sling, or preclude the subject from completing the follow-up requirements
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01290796). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search